1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. BIOCON LTD.

Biocon Ltd.

NSE: BIOCON | BSE: 532523

Slowing Down Stock
Download real time

316.55 10.25 (3.35%)

3.3M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
12S
9W
5O
0T
38,005

Market Cap

Market Leader
47.3

PE TTM

Below industry Median
-1.4

PEG TTM

PEG TTM is negative
1.8

Price to Book

Below industry Median
1.2

Beta 1Year

Very High Volatility
US FDA Approval
Biocon receives USFDA approval for Jobevne, used in cancer treatment, with a market size of ~$2 bn See details

Biocon Ltd. - BIOCON - stock price prediction, stock forecast, target price, analyst ratings from 19 analysts

Biocon Ltd. has a share price target of Rs 381, revenue growth forecast of 1.7%, and profit growth estimate of -17.9% for FY25, based on top 19 analyst calls.

Forecaster Screeners